Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 117 articles:
HTML format



Single Articles


    May 2022
  1. BHASIN D, Kumar R, Bansal S
    Man with recent myocardial infarction and heart failure.
    Heart. 2022;108:847-898.
    PubMed    


  2. VILLINES TC, Weber LA
    Trust us! Time to move on from pretest probability scores for stable chest pain.
    Heart. 2022;108:822-823.
    PubMed    


  3. FORDYCE CB, Hill CL, Mark DB, Alhanti B, et al
    Physician judgement in predicting obstructive coronary artery disease and adverse events in chest pain patients.
    Heart. 2022;108:860-867.
    PubMed     Abstract available


  4. AL-LAMEE R, Aubiniere-Robb L, Berry C
    The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond.
    Heart. 2022;108:800-806.
    PubMed     Abstract available


    April 2022
  5. SANZ-SANCHEZ J, Stefanini GG
    Timing and completeness of revascularisation in acute coronary syndromes.
    Heart. 2022;108:648-656.
    PubMed    


  6. ORTEGA-LEGASPI JM, Bravo PE
    Diagnosis and management of cardiac allograft vasculopathy.
    Heart. 2022;108:586-592.
    PubMed     Abstract available


  7. KITE TA, Ladwiniec A, Arnold JR, McCann GP, et al
    Early invasive versus non-invasive assessment in patients with suspected non-ST-elevation acute coronary syndrome.
    Heart. 2022;108:500-506.
    PubMed     Abstract available


    March 2022
  8. SZE S, Ayton SL, Moss AJ
    Should we always call 911/999 to get it right first time in suspected myocardial infarction?
    Heart. 2022 Mar 31. pii: heartjnl-2022-320918. doi: 10.1136/heartjnl-2022-320918
    PubMed    


  9. HODGINS P, McMinn M, Shah A, Reed MJ, et al
    Unscheduled care pathways in patients with myocardial infarction in Scotland.
    Heart. 2022 Mar 31. pii: heartjnl-2021-320614. doi: 10.1136/heartjnl-2021-320614
    PubMed     Abstract available


  10. BHASIN D, Kumar R, Gupta A
    Man with recent inferior wall myocardial infarction.
    Heart. 2022;108:428-492.
    PubMed    


  11. OTTO CM
    Heartbeat: delayed and inadequate treatment of acute coronary syndromes during the COVID-19 pandemic.
    Heart. 2022;108:407-409.
    PubMed    


  12. CAMMANN VL, Templin C
    The STEMI phenomenon during the COVID-19 pandemic: what is beneath the tip of the iceberg?
    Heart. 2022;108:412-413.
    PubMed    


  13. FABRIS E, Sinagra G
    Physical activity in older people: better late than never, but better early than late.
    Heart. 2022;108:328-329.
    PubMed    


    February 2022
  14. IOANNOU A
    Unusual presentation of cardiogenic shock in a young patient.
    Heart. 2022;108:211-242.
    PubMed    


  15. LEVY M, Chen Y, Clarke R, Guo Y, et al
    Gender differences in use of invasive diagnostic and therapeutic procedures for acute ischaemic heart disease in Chinese adults.
    Heart. 2022;108:292-299.
    PubMed     Abstract available


  16. BESKA B, Coakley D, MacGowan G, Adams-Hall J, et al
    Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome.
    Heart. 2022;108:203-211.
    PubMed     Abstract available


    January 2022
  17. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    PubMed    


  18. AGCA R, Smulders Y, Nurmohamed M
    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice.
    Heart. 2022;108:73-79.
    PubMed    


    November 2021
  19. MULLER D, Glarner N, Lopez-Ayala P, Puelacher C, et al
    Correspondence on "Association between cardiologist evaluation and mortality in myocardial injury after non-cardiac surgery" by Park et al.
    Heart. 2021 Nov 26. pii: heartjnl-2021-320436. doi: 10.1136/heartjnl-2021-320436
    PubMed    


  20. RAQABANI MA, Musa AM, Al-Assaf OY
    ST elevation in a critically ill patient with COVID-19: what is the emergency treatment?
    Heart. 2021;107:1703-1764.
    PubMed    


  21. SUNG KC, Hong YS, Lee JY, Lee SJ, et al
    Physical activity and the progression of coronary artery calcification.
    Heart. 2021;107:1710-1716.
    PubMed     Abstract available


  22. GULSIN GS, Moss AJ
    Coronary artery calcium paradox and physical activity.
    Heart. 2021;107:1686-1687.
    PubMed    


    October 2021
  23. DE LUCA G, Algowhary M, Uguz B, Oliveira DC, et al
    COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.
    Heart. 2021 Oct 28. pii: heartjnl-2021-319750. doi: 10.1136/heartjnl-2021-319750
    PubMed     Abstract available


  24. NORGAARD BL, Gaur S, Fairbairn TA, Douglas PS, et al
    Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319773. doi: 10.1136/heartjnl-2021-319773
    PubMed     Abstract available


  25. CHAN DZL, Kerr A, Grey C, Selak V, et al
    Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006-2018.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319853. doi: 10.1136/heartjnl-2021-319853
    PubMed     Abstract available


  26. ASLEH R
    Persistent sex differences in outcomes after coronary heart disease: time to move from observation to action.
    Heart. 2021 Oct 19. pii: heartjnl-2021-320031. doi: 10.1136/heartjnl-2021-320031
    PubMed    


  27. DE ABAJO FJ, Rodriguez-Martin S, Barreira D, Rodriguez-Miguel A, et al
    Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319754. doi: 10.1136/heartjnl-2021-319754
    PubMed     Abstract available


  28. TIJSSEN A, Snaterse M, Minneboo M, Lachman S, et al
    Weight management and determinants of weight change in patients with coronary artery disease.
    Heart. 2021;107:1552-1559.
    PubMed     Abstract available


    September 2021
  29. COELHO-LIMA J, Georgiopoulos G, Ahmed J, Adil SER, et al
    Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.
    Heart. 2021 Sep 20. pii: heartjnl-2021-319225. doi: 10.1136/heartjnl-2021-319225
    PubMed     Abstract available


  30. MCLEOD P, Adamson PD, Coffey S
    Do we need early risk stratification after ST-elevation myocardial infarction?
    Heart. 2021 Sep 20. pii: heartjnl-2021-320030. doi: 10.1136/heartjnl-2021-320030
    PubMed    


  31. LIU Y, Tan N, Huo Y, Chen S, et al
    Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.
    Heart. 2021 Sep 11. pii: heartjnl-2021-319716. doi: 10.1136/heartjnl-2021-319716
    PubMed     Abstract available


  32. LOWRY MTH, Anand A, Mills NL
    Implementing an early rule-out pathway for acute myocardial infarction in clinical practice.
    Heart. 2021 Sep 3. pii: heartjnl-2019-316242. doi: 10.1136/heartjnl-2019-316242.
    PubMed    


  33. OTTO CM
    Heartbeat: Intervention for spontaneous coronary artery dissection?
    Heart. 2021;107:1357-1359.
    PubMed    


  34. GERMAN CA, Shapiro MD
    Roadmap to a career in preventive cardiology.
    Heart. 2021;107:1435-1436.
    PubMed    


  35. ADAMSON PD
    Spontaneous coronary artery dissection: to do good or to do no harm?
    Heart. 2021;107:1362-1363.
    PubMed    


  36. BARBATO E
    Contemporary management of calcified coronary lesions.
    Heart. 2021;107:1510-1517.
    PubMed    


  37. SINGH T, Chapman AR, Dweck MR, Mills NL, et al
    MINOCA: a heterogenous group of conditions associated with myocardial damage.
    Heart. 2021;107:1458-1464.
    PubMed     Abstract available


    August 2021
  38. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available


  39. BAINEY KR, Zheng Y, Coulden R, Sonnex E, et al
    Remote ischaemic conditioning in ST elevation myocardial infarction: a registry-based randomised trial.
    Heart. 2021 Aug 20. pii: heartjnl-2021-319455. doi: 10.1136/heartjnl-2021-319455
    PubMed     Abstract available


    July 2021
  40. MASSERA D, Hu M, Delaney JA, Bartz TM, et al
    Adverse cardiac mechanics and incident coronary heart disease in the Cardiovascular Health Study.
    Heart. 2021 Jul 13. pii: heartjnl-2021-319296. doi: 10.1136/heartjnl-2021-319296
    PubMed     Abstract available


  41. DARMON A, Ducrocq G
    Early stopping of a randomised trial for efficacy: a medical, ethical and regulatory challenge.
    Heart. 2021;107:1109-1110.
    PubMed    


  42. ALMARZOOQ ZI, Colantonio LD, Okin PM, Richman JS, et al
    Risk for cardiovascular events following 'microsize' versus usual myocardial infarctions.
    Heart. 2021;107:1152-1159.
    PubMed     Abstract available


    June 2021
  43. PHREANER N, Daniels LB
    Sex differences in type 2 myocardial infarction: learning that we still have a lot to learn.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319432. doi: 10.1136/heartjnl-2021-319432
    PubMed    


  44. LEEDY D, Tiwana JK, Mamas M, Hira R, et al
    Coronary revascularisation outcomes in patients with cancer.
    Heart. 2021 Jun 15. pii: heartjnl-2020-318531. doi: 10.1136/heartjnl-2020-318531
    PubMed     Abstract available


  45. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    PubMed    


  46. TAM DY, Rocha RV, Fang J, Ouzounian M, et al
    Multiple arterial coronary bypass grafting is associated with greater survival in women.
    Heart. 2021;107:888-894.
    PubMed     Abstract available


    May 2021
  47. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available


  48. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    PubMed     Abstract available


  49. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available


  50. KOTECHA D, Garcia-Guimaraes M, Premawardhana D, Pellegrini D, et al
    Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection.
    Heart. 2021 May 18. pii: heartjnl-2020-318914. doi: 10.1136/heartjnl-2020-318914
    PubMed     Abstract available


  51. CHUA A, Adams D, Dey D, Blankstein R, et al
    Coronary artery disease in East and South Asians: differences observed on cardiac CT.
    Heart. 2021 May 13. pii: heartjnl-2020-318929. doi: 10.1136/heartjnl-2020-318929
    PubMed     Abstract available


  52. CADER FA, Yancy CW, Banerjee S
    To be, or not to be BAME, in the time of COVID-19: does it matter?
    Heart. 2021;107:692-693.
    PubMed    


  53. BODY R
    Trial is error? Evaluating the effectiveness of single-troponin diagnostic pathways.
    Heart. 2021;107:690-691.
    PubMed    


  54. BARNES C, Fatovich DM, Macdonald SPJ, Alcock RF, et al
    Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes.
    Heart. 2021;107:721-727.
    PubMed     Abstract available


  55. PECK KY, Andrianopoulos N, Dinh D, Roberts L, et al
    Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome.
    Heart. 2021;107:728-733.
    PubMed     Abstract available


    April 2021
  56. KIMENAI DM, Lindahl B, Chapman AR, Baron T, et al
    Sex differences in investigations and outcomes among patients with type 2 myocardial infarction.
    Heart. 2021 Apr 20. pii: heartjnl-2021-319118. doi: 10.1136/heartjnl-2021-319118
    PubMed     Abstract available


  57. MCGOVERN L, Cosgrave J
    Axial flow ventricular assist devices in cardiogenic shock complicating acute myocardial infarction.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318226. doi: 10.1136/heartjnl-2020-318226.
    PubMed     Abstract available


  58. ZHANG KW
    Out of the woods, but still in the weeds: When cancer therapy becomes part of a chronic condition.
    Heart. 2021;107:607-608.
    PubMed    


    March 2021
  59. STOREY RF
    Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.
    Heart. 2021 Mar 19. pii: heartjnl-2020-318872. doi: 10.1136/heartjnl-2020-318872
    PubMed    


  60. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    PubMed     Abstract available


  61. RASHID M, Timmis A, Kinnaird T, Curzen N, et al
    Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic.
    Heart. 2021 Mar 8. pii: heartjnl-2020-318356. doi: 10.1136/heartjnl-2020-318356.
    PubMed     Abstract available


  62. SIMON T, Danchin N
    Beware of simple explanations.
    Heart. 2021;107:348-349.
    PubMed    


  63. KUMAR R, Bhasin D, Isser HS
    Typical chest pain and an ominous ECG.
    Heart. 2021;107:380-432.
    PubMed    


    February 2021
  64. DANCHIN N, Marijon E
    COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether?
    Heart. 2021 Feb 1. pii: heartjnl-2020-318646. doi: 10.1136/heartjnl-2020-318646.
    PubMed    


    January 2021
  65. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available


  66. GIANNOPOULOS G, Karageorgiou S, Vrachatis D, Anagnostopoulos I, et al
    A stand-alone structured educational programme after myocardial infarction: a randomised study.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318414. doi: 10.1136/heartjnl-2020-318414
    PubMed     Abstract available


  67. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    PubMed     Abstract available


  68. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available


  69. RYAN M, Morgan H, Petrie MC, Perera D, et al
    Coronary revascularisation in patients with ischaemic cardiomyopathy.
    Heart. 2021 Jan 12. pii: heartjnl-2020-316856. doi: 10.1136/heartjnl-2020-316856
    PubMed     Abstract available


  70. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available


  71. GHOBRIAL M, Haley HA, Gosling R, Rammohan V, et al
    The new role of diagnostic angiography in coronary physiological assessment.
    Heart. 2021 Jan 8. pii: heartjnl-2020-318289. doi: 10.1136/heartjnl-2020-318289.
    PubMed     Abstract available


  72. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available


  73. KOK WE
    Too often and too early: the risk of cardiac ischaemia in adult survivors of childhood cancer.
    Heart. 2021;107:6-7.
    PubMed    


  74. ONISHI T, Nakano Y, Hirano KI, Nagasawa Y, et al
    Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients.
    Heart. 2021;107:127-134.
    PubMed     Abstract available


  75. FEIJEN EAM, van Dalen EC, van der Pal HJH, Reulen RC, et al
    Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study.
    Heart. 2021;107:33-40.
    PubMed     Abstract available


  76. JOLICOEUR EM, Verheye S, Henry TD, Joseph L, et al
    A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Heart. 2021;107:41-46.
    PubMed     Abstract available


    December 2020
  77. DE FILIPPO O, D'Ascenzo F, Deferrari GM
    COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
    Heart. 2020;106:1786-1787.
    PubMed    


    November 2020
  78. MINTZ GS, Ali Z, Maehara A
    Use of intracoronary imaging to guide optimal percutaneous coronary intervention procedures and outcomes.
    Heart. 2020 Nov 30. pii: heartjnl-2020-316745. doi: 10.1136/heartjnl-2020-316745
    PubMed    


  79. OTTO CM
    Heartbeat: exercise improves quality of life after acute myocardial infarction.
    Heart. 2020;106:1705-1706.
    PubMed    


    October 2020
  80. DING Q, Spatz ES, Lipska KJ, Lin H, et al
    Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults.
    Heart. 2020 Oct 20. pii: heartjnl-2020-317101. doi: 10.1136/heartjnl-2020-317101
    PubMed     Abstract available


  81. DE BACQUER D, van de Luitgaarden IAT, De Smedt D, Vynckier P, et al
    Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile.
    Heart. 2020 Oct 16. pii: heartjnl-2020-317549. doi: 10.1136/heartjnl-2020-317549
    PubMed     Abstract available


  82. MOHAMMAD MA, Koul S, Olivecrona GK, Gtberg M, et al
    Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
    Heart. 2020 Oct 6. pii: heartjnl-2020-317685. doi: 10.1136/heartjnl-2020-317685.
    PubMed     Abstract available


  83. NIJJER SS, Petraco R, Sen S
    Optimal management of acute coronary syndromes in the era of COVID-19.
    Heart. 2020;106:1609-1616.
    PubMed    


    August 2020
  84. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available


    July 2020
  85. WILLIAMS C, Brown DL
    Effect of random deferral of percutaneous coronary intervention in patients with diabetes and stable ischaemic heart disease.
    Heart. 2020 Jul 21. pii: heartjnl-2019-316432. doi: 10.1136/heartjnl-2019-316432
    PubMed     Abstract available


    June 2020
  86. NAZIR MS, Mittal TK, Weir-McCall J, Nieman K, et al
    Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice.
    Heart. 2020 Jun 19. pii: heartjnl-2019-315607. doi: 10.1136/heartjnl-2019-315607
    PubMed     Abstract available


  87. HOOLE SP, Bambrough P
    Recent advances in percutaneous coronary intervention.
    Heart. 2020 Jun 10. pii: heartjnl-2019-315707. doi: 10.1136/heartjnl-2019-315707
    PubMed     Abstract available


  88. BRIDGMAN PG
    The comorbid patient: does your heart sink?
    Heart. 2020;106:790.
    PubMed    


  89. ALKHALIL M, Spence MS, Owens C
    Ischaemic changes during transcatheter aortic valve implantation.
    Heart. 2020;106:801-866.
    PubMed    


  90. CROWE F, Zemedikun DT, Okoth K, Adderley NJ, et al
    Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK.
    Heart. 2020;106:810-816.
    PubMed     Abstract available


    May 2020
  91. KEULARDS DCJ, Fournier S, van 't Veer M, Colaiori I, et al
    Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement.
    Heart. 2020 May 29. pii: heartjnl-2020-316689. doi: 10.1136/heartjnl-2020-316689
    PubMed     Abstract available


  92. VAGO H, Szabo L, Dohy Z, Czimbalmos C, et al
    Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries.
    Heart. 2020 May 23. pii: heartjnl-2019-316295. doi: 10.1136/heartjnl-2019-316295
    PubMed     Abstract available


  93. AHMADVAZIR S, Pradhan J, Khattar RS, Senior R, et al
    Sex-based impact of carotid plaque in patients with chest pain undergoing stress echocardiography.
    Heart. 2020 May 22. pii: heartjnl-2019-316507. doi: 10.1136/heartjnl-2019-316507
    PubMed     Abstract available


  94. KOO CY, Aung AT, Chen Z, Kristanto W, et al
    Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting.
    Heart. 2020 May 18. pii: heartjnl-2019-316118. doi: 10.1136/heartjnl-2019-316118
    PubMed     Abstract available


  95. BURDEN AF
    Tub bathing and heart disease.
    Heart. 2020;106:710.
    PubMed    


  96. NEUMANN JT, Twerenbold R
    How do comorbidities influence troponin concentrations?
    Heart. 2020;106:634-635.
    PubMed    


  97. BING R, Mitchell AJ, Newby DE
    Chest pain: when in doubt....
    Heart. 2020;106:690-706.
    PubMed    


    April 2020
  98. ADAMSON PD, Mills NL, Newby DE, Troughton RW, et al
    Response to: 'Convalescent troponin and cardiovascular death following acute coronary syndrome' by Kawada.
    Heart. 2020;106:545-546.
    PubMed    


  99. KAWADA T
    Convalescent troponin and cardiovascular death in patients with acute coronary syndrome.
    Heart. 2020;106:545.
    PubMed    


  100. GALLACHER PJ, Shah ASV
    Walking the tightrope: cardiovascular risk prediction in patients after acute coronary syndrome.
    Heart. 2020;106:484-486.
    PubMed    


  101. MEHILLI J, Presbitero P
    Coronary artery disease and acute coronary syndrome in women.
    Heart. 2020;106:487-492.
    PubMed     Abstract available


  102. POPPE KK, Doughty RN, Wells S, Wu B, et al
    Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome.
    Heart. 2020;106:506-511.
    PubMed     Abstract available


  103. PARKINSON J, Minton J, Bouttell J, Lewsey J, et al
    Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974-2015?
    Heart. 2020;106:584-589.
    PubMed     Abstract available


    March 2020
  104. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available


  105. WALD DS, Casey-Gillman O, Comer K, Mansell JS, et al
    Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative.
    Heart. 2020 Mar 10. pii: heartjnl-2019-316227. doi: 10.1136/heartjnl-2019-316227
    PubMed     Abstract available


  106. ARNOLD SV
    Can we improve the appropriateness of PCI?
    Heart. 2020;106:405-406.
    PubMed    


  107. FORD TJ, Berry C
    Angina: contemporary diagnosis and management.
    Heart. 2020;106:387-398.
    PubMed    


  108. MOSS AJ, Jordan A, Carpenter JP
    Seventy-one-year-old man with transient left bundle branch block.
    Heart. 2020;106:386-398.
    PubMed    


  109. CAULDWELL M, Steer PJ, von Klemperer K, Kaler M, et al
    Maternal and neonatal outcomes in women with history of coronary artery disease.
    Heart. 2020;106:380-386.
    PubMed     Abstract available


    February 2020
  110. IHDAYHID AR, Sapontis J
    The fractional flow reserve grey zone: a blueprint for the future of coronary revascularisation.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316435. doi: 10.1136/heartjnl-2019-316435
    PubMed    


  111. HENNIGAN B, Berry C, Collison D, Corcoran D, et al
    Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316075. doi: 10.1136/heartjnl-2019-316075
    PubMed     Abstract available


  112. LUPERCIO F, Giancaterino S, Villablanca PA, Han F, et al
    P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2020 Feb 7. pii: heartjnl-2019-315963. doi: 10.1136/heartjnl-2019-315963.
    PubMed     Abstract available


  113. MARIATHAS M, Curzen N
    Use of troponins in clinical practice: Evidence against the use of troponins in clinical practice.
    Heart. 2020;106:251-252.
    PubMed    


  114. COLLINSON PO, Apple F, Jaffe AS
    Use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice.
    Heart. 2020;106:253-255.
    PubMed    


  115. LITWIN SE, Coles A, Hill CL, Alhanti B, et al
    Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.
    Heart. 2020;106:273-279.
    PubMed     Abstract available


  116. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.
    PubMed    


    December 2019
  117. YANG JX, Stevenson MJ, Valsdottir L, Ho K, et al
    Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315835. doi: 10.1136/heartjnl-2019-315835
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: